It is also reported that increasing cAMP levels using inhibitor of phosphodiesterase 4 (PDE4) significantly alleviated symptoms of FXS (Gurney et al, 2017; Berry-Kravis et al, 2021; Rosenheck et al, 2021). Here, PDE4A is linked to fragile X syndrome.